Impact of microRNA miR-345 in blood on survival and response in 144 patients with metastatic colorectal cancer treated with third-line cetuximab and irinotecan.
Jakob Vasehus Schou
No relevant relationships to disclose
Klaus Kaae Andersen
No relevant relationships to disclose
Benny Vittrup Jensen
Consultant or Advisory Role - Merck Serono
Research Funding - Merck Serono
Dorte Lisbet Nielsen
No relevant relationships to disclose
Estrid V. Høgdall
No relevant relationships to disclose
Julia S. Johansen
No relevant relationships to disclose